BG
MNTA

BlackRock Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

BlackRock Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.01M Buy
133,661
+42,434
+47% +$560K ﹤0.01% 1768
2016
Q3 		$1.07M Buy
91,227
+8,196
+10% +$96.4K ﹤0.01% 1999
2016
Q2 		$897K Sell
83,031
-24,007
-22% -$248K ﹤0.01% 2020
2016
Q1 		$989K Buy
107,038
+11,403
+12% +$123K ﹤0.01% 1951
2015
Q4 		$1.42M Buy
95,635
+2,305
+2% +$38.6K ﹤0.01% 1676
2015
Q3 		$1.53M Buy
93,330
+10,350
+12% +$212K ﹤0.01% 1645
2015
Q2 		$1.89M Buy
82,980
+28,343
+52% +$564K ﹤0.01% 1594
2015
Q1 		$830K Buy
54,637
+8,749
+19% +$114K ﹤0.01% 1969
2014
Q4 		$553K Sell
45,888
-39,623
-46% -$453K ﹤0.01% 2194
2014
Q3 		$969K Sell
85,511
-32,193
-27% -$367K ﹤0.01% 1808
2014
Q2 		$1.42M Buy
117,704
+47,877
+69% +$565K ﹤0.01% 1635
2014
Q1 		$814K Sell
69,827
-121,935
-64% -$2.06M ﹤0.01% 2075
2013
Q4 		$3.39M Buy
191,762
+1,084
+0.6% +$18.2K ﹤0.01% 1216
2013
Q3 		$2.74M Buy
190,678
+24,681
+15% +$378K ﹤0.01% 1306
2013
Q2 		$2.5M Buy
+165,997
New +$2.19M ﹤0.01% 1200

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock Group's MNTA Position: Q4 2016 in Review

BlackRock Group increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 47% in Q4 2016, buying an estimated $560K and bringing the position to 133,661 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1768.

BlackRock Group first reported a position in MNTA in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.39M in Q4 2013. 160 funds tracked by Wall St. Rank hold MNTA as of Q4 2016.

  • BlackRock Group held 133,661 shares of Momenta Pharmaceuticals, Inc. worth $2.01M as of Q4 2016.
  • BlackRock Group bought 42,434 Momenta Pharmaceuticals, Inc. shares in Q4 2016, an estimated $560K.
  • Momenta Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1768 holding.
  • BlackRock Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Momenta Pharmaceuticals, Inc. position peaked at $3.39M in Q4 2013.
  • 160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.